Variation in the biologic and biochemical characteristics of human menopausal gonadotropin

A. S. Cook, B. W. Webster, P. F. Terranova, B. A. Keel

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Lot differences in the biopotency of human menopausal gonadotropin (hMG) were evaluated and the potential biochemical basis was investigated. The in vivo biopotency of hMG was assessed by a unique bioassay that evaluates the number of ova shed in the cyclic hamster in response to hMG administration. Significant variation in hMG lots was observed using this assay. When subjected to chromatofocusing, hMG displayed five immunoreactive follicle-stimulating hormone (FSH) isohormones and nine luteinizing hormone (LH) isohormones. The relative distribution of FSH, but not LH isohormones, was slightly but significantly different between the lots tested. These data indicate that significant differences exist in the ability of commercially available hMG to stimulate follicular development and ovulation. The biochemical basis for these differences in in vivo biopotency remains to be elucidated.

Original languageEnglish (US)
Pages (from-to)704-712
Number of pages9
JournalFertility and sterility
Volume49
Issue number4
StatePublished - Jan 1 1988

Fingerprint

Menotropins
Follicle Stimulating Hormone
Luteinizing Hormone
Ovulation
Cricetinae
Biological Assay
Ovum

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Variation in the biologic and biochemical characteristics of human menopausal gonadotropin. / Cook, A. S.; Webster, B. W.; Terranova, P. F.; Keel, B. A.

In: Fertility and sterility, Vol. 49, No. 4, 01.01.1988, p. 704-712.

Research output: Contribution to journalArticle

Cook, A. S. ; Webster, B. W. ; Terranova, P. F. ; Keel, B. A. / Variation in the biologic and biochemical characteristics of human menopausal gonadotropin. In: Fertility and sterility. 1988 ; Vol. 49, No. 4. pp. 704-712.
@article{0875f7ca088f4d9a9cd13024c53b8c51,
title = "Variation in the biologic and biochemical characteristics of human menopausal gonadotropin",
abstract = "Lot differences in the biopotency of human menopausal gonadotropin (hMG) were evaluated and the potential biochemical basis was investigated. The in vivo biopotency of hMG was assessed by a unique bioassay that evaluates the number of ova shed in the cyclic hamster in response to hMG administration. Significant variation in hMG lots was observed using this assay. When subjected to chromatofocusing, hMG displayed five immunoreactive follicle-stimulating hormone (FSH) isohormones and nine luteinizing hormone (LH) isohormones. The relative distribution of FSH, but not LH isohormones, was slightly but significantly different between the lots tested. These data indicate that significant differences exist in the ability of commercially available hMG to stimulate follicular development and ovulation. The biochemical basis for these differences in in vivo biopotency remains to be elucidated.",
author = "Cook, {A. S.} and Webster, {B. W.} and Terranova, {P. F.} and Keel, {B. A.}",
year = "1988",
month = "1",
day = "1",
language = "English (US)",
volume = "49",
pages = "704--712",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Variation in the biologic and biochemical characteristics of human menopausal gonadotropin

AU - Cook, A. S.

AU - Webster, B. W.

AU - Terranova, P. F.

AU - Keel, B. A.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Lot differences in the biopotency of human menopausal gonadotropin (hMG) were evaluated and the potential biochemical basis was investigated. The in vivo biopotency of hMG was assessed by a unique bioassay that evaluates the number of ova shed in the cyclic hamster in response to hMG administration. Significant variation in hMG lots was observed using this assay. When subjected to chromatofocusing, hMG displayed five immunoreactive follicle-stimulating hormone (FSH) isohormones and nine luteinizing hormone (LH) isohormones. The relative distribution of FSH, but not LH isohormones, was slightly but significantly different between the lots tested. These data indicate that significant differences exist in the ability of commercially available hMG to stimulate follicular development and ovulation. The biochemical basis for these differences in in vivo biopotency remains to be elucidated.

AB - Lot differences in the biopotency of human menopausal gonadotropin (hMG) were evaluated and the potential biochemical basis was investigated. The in vivo biopotency of hMG was assessed by a unique bioassay that evaluates the number of ova shed in the cyclic hamster in response to hMG administration. Significant variation in hMG lots was observed using this assay. When subjected to chromatofocusing, hMG displayed five immunoreactive follicle-stimulating hormone (FSH) isohormones and nine luteinizing hormone (LH) isohormones. The relative distribution of FSH, but not LH isohormones, was slightly but significantly different between the lots tested. These data indicate that significant differences exist in the ability of commercially available hMG to stimulate follicular development and ovulation. The biochemical basis for these differences in in vivo biopotency remains to be elucidated.

UR - http://www.scopus.com/inward/record.url?scp=0023916762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023916762&partnerID=8YFLogxK

M3 - Article

C2 - 3127248

AN - SCOPUS:0023916762

VL - 49

SP - 704

EP - 712

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 4

ER -